GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Sudarshan Pharma Industries Ltd

Sudarshan Pharma to consider Q2 FY27 results and fundraising on Oct 29

BOARD ◆ Monitor Closely LOW RISK
📅 Filed on BSE: 26 Oct 2026, 06:57 PM IST  ·  BSE ID: 38af59b0-7d7c-4e6d-acc6-37c79b12d36c
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board will meet on October 29 to discuss financial results and a plan to raise more money.
🤖 AI Summary
  • Board meeting scheduled October 29, 2026, to approve Q2 FY27 financial results.
  • Also to consider and approve a proposal for raising funds via various instruments.
  • Funds can be raised through equity shares, convertible securities, warrants, or debt.
  • Trading window to remain closed until 48 hours after financial results declaration.
🏢 How This Affects the Company
📈
Business Impact
The company is assessing its financial performance for the period and actively planning for future growth through capital infusion.
💰
Financial Impact
Approval of financial results will provide clarity on recent performance. The fundraising proposal indicates a need for capital, impacting future balance sheet structure and leverage.
⚠️
Risk Impact
The company is proactively managing its capital structure to fund future operations and expansion.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders. Monitor the outcome of the board meeting for future disclosures.
👤
Who Is Affected
All shareholders will be affected by the financial results and any approved fundraising activities which could impact future equity dilution or debt levels.
🔍
Management Signal
Management is focused on transparently reporting financial performance and strategically planning for capital requirements to support business expansion.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
October 29, 2026: Board meeting outcome on financial results.
October 29, 2026: Board meeting outcome on fundraising proposal.
48 hours post-results: Trading window reopening announcement.
LOW RISK This is a standard procedural disclosure regarding upcoming board meetings and financial reporting.
💡 Investor Takeaway
Sudarshan Pharma will announce Q2 FY27 results on October 29, 2026. The board will also consider a proposal to raise funds through equity, convertible securities, warrants, or debt instruments.
❓ Frequently Asked Questions
When is the Sudarshan Pharma Industries board meeting scheduled?
The board meeting of Sudarshan Pharma Industries is scheduled for Thursday, October 29, 2026.
What will be discussed at the Sudarshan Pharma board meeting on October 29, 2026?
The meeting will discuss and approve unaudited standalone and consolidated financial results for the quarter and half-year ending September 30, 2026, and consider a fundraising proposal.
How can Sudarshan Pharma raise funds?
The company may raise funds by issuing equity shares, convertible securities, warrants, or debt securities through private placement or other approved methods.
When will the trading window reopen for Sudarshan Pharma?
The trading window will remain closed until 48 hours after the declaration of the financial results for the quarter and half-year ended September 30, 2026.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.